Zebra Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,388	Closed	-$225K	–	124
2021 Q4	$225K	Sell	11,388 -4,198	-27%	-$85.2K	0.36%	107
2021 Q3	$307K	Buy	+15,586	New	+$326K	0.37%	101
2021 Q1	–	Sell	-46,989	Closed	-$1.23M	–	183
2020 Q4	$1.23M	Buy	46,989 +1,756	+4%	+$37K	1.56%	4
2020 Q3	$787K	Buy	45,233 +11,490	+34%	+$183K	1.22%	11
2020 Q2	$568K	Sell	33,743 -3,903	-10%	-$54.8K	0.82%	28
2020 Q1	$448K	Sell	37,646 -962	-2%	-$11.9K	0.72%	38
2019 Q4	$467K	Buy	38,608 +13,199	+52%	+$184K	0.41%	82
2019 Q3	$359K	Sell	25,409 -13,798	-35%	-$170K	0.39%	98
2019 Q2	$437K	Buy	39,207 +1,688	+4%	+$18.8K	0.23%	132
2019 Q1	$440K	Buy	37,519 +5,230	+16%	+$65K	0.23%	124
2018 Q4	$431K	Sell	32,289 -14,438	-31%	-$191K	0.27%	153
2018 Q3	$655K	Sell	46,727 -10,452	-18%	-$146K	0.3%	102
2018 Q2	$899K	Sell	57,179 -5,567	-9%	-$96.8K	0.38%	109
2018 Q1	$1.03M	Buy	62,746 +8,587	+16%	+$159K	0.37%	124
2017 Q4	$978K	Buy	54,159 +20,268	+60%	+$367K	0.33%	144
2017 Q3	$654K	Buy	+33,891	New	+$505K	0.21%	196